When placental abruption occurs alongside preeclampsia with severe features, management must address both conditions simultaneously. Seizure prevention becomes a critical priority that shapes the overall clinical approach.
This protocol applies to patients with placental abruption who also have preeclampsia with severe features. The presence of severe preeclampsia directly determines which interventions are indicated and which clinical risks must be proactively managed.
Pharmacologic seizure prophylaxis is a key element of management in this setting. The full protocol specifies which agent is used, the administration sequence, and the clinical decision points involved — details that go beyond what is summarised here.
The primary measurable target is absence of eclamptic seizures. The structured protocol defines the monitoring parameters and management steps required to achieve and sustain this outcome.
DOI: 10.1016/j.ajog.2022.06.059
Magnesium sulfate is not used during this range for neuroprotection, although it should be used for seizure prophylaxis in cases of preeclampsia with severe features.
View source ↗